Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Plasmapheresis
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Complications of plasmapheresis therapy=== Though plasmapheresis is helpful in certain medical conditions, like any other therapy, there are potential risks and complications. Insertion of a rather large [[intravenous]] catheter can lead to bleeding, lung puncture (depending on the site of catheter insertion), and, if the catheter is left in too long, it can get infected.<ref name="madore2002">{{cite journal |last1=Madore |first1=François |title=Plasmapheresis |journal=Critical Care Clinics |date=April 2002 |volume=18 |issue=2 |pages=375–392 |doi=10.1016/S0749-0704(01)00010-0 |url=https://www.criticalcare.theclinics.com/article/S0749-0704(01)00010-0/fulltext |access-date=5 January 2025|url-access=subscription }}</ref> Aside from placing the catheter, the procedure itself has complications. When patient blood is outside of the body passing through the plasmapheresis machine, the blood has a tendency to clot. To reduce this tendency, in one common protocol,{{which|date=July 2012}} [[sodium citrate]] is infused while the blood is running through the circuit. Citrate binds to [[calcium]] in the blood, calcium being essential for blood to clot. Citrate is very effective in preventing blood from clotting; however, its use can lead to life-threateningly low calcium levels. This can be detected using the [[Chvostek's sign]] or [[Trousseau sign of latent tetany|Trousseau's sign]]. To prevent this complication, calcium is infused intravenously while the patient is undergoing the plasmapheresis; in addition, calcium supplementation by mouth may also be given.<ref name="pinketal2017">{{cite journal |last1=Pink |first1=J. |last2=Bell |first2=B. |last3=Kotsiou |first3=G. |last4=Wright |first4=S. |last5=Thyer |first5=J. |title=Safe and sustainable plasmapheresis |journal=ISBT Science Series |date=November 2017 |volume=12 |issue=4 |pages=471–482 |doi=10.1111/voxs.12387 |url=https://onlinelibrary.wiley.com/doi/full/10.1111/voxs.12387 |access-date=5 January 2025|url-access=subscription }}</ref> Other complications include: * Bleeding or [[hematoma]] from needle placement * [[Hypotension]] * Potential exposure to blood products, with risk of [[transfusion reaction]]s or transfusion transmitted diseases * Suppression of the patient's [[immune system]]
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)